Trade Outset Medical, Inc. - OM CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.13 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.025457% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003235% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 20% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Outset Medical Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 22.28 |
Open* | 21.98 |
1-Year Change* | -3% |
Day's Range* | 21.53 - 22.11 |
52 wk Range | 11.41-30.55 |
Average Volume (10 days) | 396.32K |
Average Volume (3 months) | 10.90M |
Market Cap | 1.10B |
P/E Ratio | -100.00K |
Shares Outstanding | 49.23M |
Revenue | 118.29M |
EPS | -3.51 |
Dividend (Yield %) | N/A |
Beta | -100.00K |
Next Earnings Date | Jul 31, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jun 2, 2023 | 22.28 | 0.48 | 2.20% | 21.80 | 22.42 | 21.49 |
Jun 1, 2023 | 21.80 | 1.07 | 5.16% | 20.73 | 22.05 | 20.46 |
May 31, 2023 | 20.83 | -0.22 | -1.05% | 21.05 | 21.21 | 20.24 |
May 30, 2023 | 21.22 | -0.08 | -0.38% | 21.30 | 21.67 | 20.71 |
May 26, 2023 | 21.38 | 1.76 | 8.97% | 19.62 | 21.41 | 19.48 |
May 25, 2023 | 20.20 | 0.23 | 1.15% | 19.97 | 20.26 | 19.47 |
May 24, 2023 | 20.30 | 0.77 | 3.94% | 19.53 | 20.49 | 19.47 |
May 23, 2023 | 20.13 | -1.50 | -6.93% | 21.63 | 22.29 | 19.73 |
May 22, 2023 | 22.06 | 1.31 | 6.31% | 20.75 | 22.32 | 20.74 |
May 19, 2023 | 21.18 | 0.19 | 0.91% | 20.99 | 21.76 | 20.99 |
May 18, 2023 | 21.03 | 1.50 | 7.68% | 19.53 | 21.14 | 19.47 |
May 17, 2023 | 20.08 | 0.10 | 0.50% | 19.98 | 20.22 | 19.51 |
May 16, 2023 | 20.14 | 0.37 | 1.87% | 19.77 | 20.17 | 19.48 |
May 15, 2023 | 20.11 | 0.09 | 0.45% | 20.02 | 20.32 | 19.61 |
May 12, 2023 | 19.98 | 0.01 | 0.05% | 19.97 | 20.28 | 19.62 |
May 11, 2023 | 20.15 | -0.54 | -2.61% | 20.69 | 20.94 | 19.80 |
May 10, 2023 | 20.87 | 0.59 | 2.91% | 20.28 | 20.99 | 20.21 |
May 9, 2023 | 20.26 | 0.50 | 2.53% | 19.76 | 20.49 | 19.19 |
May 8, 2023 | 19.93 | -0.09 | -0.45% | 20.02 | 20.24 | 18.24 |
May 5, 2023 | 20.79 | -0.18 | -0.86% | 20.97 | 22.48 | 20.79 |
Outset Medical, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Monday, July 31, 2023 | ||
Time (UTC) 10:59 | Country US
| Event Q2 2023 Outset Medical Inc Earnings Release Q2 2023 Outset Medical Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
Time (UTC) 10:59 | Country US
| Event Q3 2023 Outset Medical Inc Earnings Release Q3 2023 Outset Medical Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 115.375 | 102.602 | 49.935 | 15.078 | 2.007 |
Revenue | 115.375 | 102.602 | 49.935 | 15.078 | 2.007 |
Cost of Revenue, Total | 97.542 | 94.994 | 62.972 | 32.88 | 8.122 |
Gross Profit | 17.833 | 7.608 | -13.037 | -17.802 | -6.115 |
Total Operating Expense | 277.761 | 233.121 | 168.969 | 85.385 | 48.57 |
Selling/General/Admin. Expenses, Total | 129.997 | 101.386 | 75.58 | 29.178 | 17.532 |
Research & Development | 48.855 | 36.741 | 28.85 | 23.327 | 22.916 |
Operating Income | -162.386 | -130.519 | -119.034 | -70.307 | -46.563 |
Interest Income (Expense), Net Non-Operating | -0.275 | -1.217 | -2.365 | -1.772 | -2.93 |
Other, Net | 0 | 0 | -0.093 | 3.8 | -0.262 |
Net Income Before Taxes | -162.661 | -131.736 | -121.492 | -68.279 | -49.755 |
Net Income After Taxes | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
Net Income Before Extra. Items | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
Net Income | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
Total Adjustments to Net Income | 0 | 42.168 | -17.163 | -23.3 | |
Income Available to Common Excl. Extra. Items | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
Income Available to Common Incl. Extra. Items | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
Diluted Net Income | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
Diluted Weighted Average Shares | 48.161 | 45.589 | 42.722 | 45.2225 | 45.2225 |
Diluted EPS Excluding Extraordinary Items | -3.38357 | -2.89401 | -1.85675 | -1.88981 | -1.61601 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Diluted Normalized EPS | -3.36512 | -2.89401 | -1.82007 | -1.88981 | -1.61601 |
Unusual Expense (Income) | 1.367 | 0 | 1.567 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total revenue | 33.467 | 32.007 | 27.761 | 25.057 | 30.55 |
Revenue | 33.467 | 32.007 | 27.761 | 25.057 | 30.55 |
Cost of Revenue, Total | 27.039 | 26.734 | 23.425 | 21.275 | 26.108 |
Gross Profit | 6.428 | 5.273 | 4.336 | 3.782 | 4.442 |
Total Operating Expense | 76.952 | 73.198 | 68.76 | 68.778 | 67.025 |
Selling/General/Admin. Expenses, Total | 36.12 | 33.653 | 32.276 | 33.982 | 30.086 |
Research & Development | 13.793 | 11.444 | 13.059 | 13.521 | 10.831 |
Operating Income | -43.485 | -41.191 | -40.999 | -43.721 | -36.475 |
Interest Income (Expense), Net Non-Operating | -0.294 | -0.189 | 0.238 | -0.022 | -0.302 |
Other, Net | 0 | ||||
Net Income Before Taxes | -43.779 | -41.38 | -40.761 | -43.743 | -36.777 |
Net Income After Taxes | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Net Income Before Extra. Items | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Net Income | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Total Adjustments to Net Income | |||||
Income Available to Common Excl. Extra. Items | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Income Available to Common Incl. Extra. Items | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Diluted Net Income | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
Diluted Weighted Average Shares | 48.783 | 49.139 | 48.129 | 47.882 | 47.487 |
Diluted EPS Excluding Extraordinary Items | -0.90136 | -0.8434 | -0.84733 | -0.91556 | -0.77689 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.90136 | -0.82532 | -0.84733 | -0.91556 | -0.77689 |
Unusual Expense (Income) | 1.367 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 373.645 | 409.802 | 345.911 | 79.646 | 147.646 |
Cash and Short Term Investments | 287.502 | 339.488 | 314.87 | 69.378 | 142.782 |
Cash & Equivalents | 73.222 | 182.348 | 294.972 | 36.226 | 33.264 |
Short Term Investments | 214.28 | 157.14 | 19.898 | 33.152 | 109.518 |
Total Receivables, Net | 28.07 | 25.6 | 6.468 | 3.914 | 1.088 |
Accounts Receivable - Trade, Net | 28.07 | 25.6 | 6.468 | 3.914 | 1.088 |
Total Inventory | 51.476 | 39.185 | 18.384 | 4.596 | 3.022 |
Prepaid Expenses | 6.597 | 5.529 | 6.189 | 1.058 | 0.754 |
Total Assets | 400.115 | 463.464 | 403.829 | 88.366 | 151.13 |
Property/Plant/Equipment, Total - Net | 21.993 | 20.195 | 23.251 | 7.895 | 2.926 |
Property/Plant/Equipment, Total - Gross | 32.8 | 27.849 | 28.239 | 10.565 | 5.149 |
Accumulated Depreciation, Total | -10.807 | -7.654 | -4.988 | -2.67 | -2.223 |
Other Long Term Assets, Total | 4.477 | 33.467 | 34.667 | 0.825 | 0.558 |
Total Current Liabilities | 51.949 | 51.695 | 36.692 | 24.91 | 10.213 |
Accounts Payable | 0.603 | 1.763 | 4.948 | 4.96 | 3.373 |
Accrued Expenses | 35.575 | 39.575 | 26.578 | 10.43 | 5.349 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 7.509 | 0.01 | ||
Other Current Liabilities, Total | 15.771 | 10.357 | 5.166 | 2.011 | 1.481 |
Total Liabilities | 154.125 | 89.383 | 75.22 | 51.107 | 46.796 |
Total Long Term Debt | 96.336 | 29.762 | 29.674 | 21.561 | 28.355 |
Long Term Debt | 96.336 | 29.762 | 29.674 | 21.561 | 28.346 |
Capital Lease Obligations | 0 | 0.009 | |||
Other Liabilities, Total | 5.84 | 7.926 | 8.854 | 4.636 | 8.228 |
Total Equity | 245.99 | 374.081 | 328.609 | 37.259 | 104.334 |
Redeemable Preferred Stock | 0 | 0 | 0 | 409.446 | 392.284 |
Common Stock | 0.048 | 0.047 | 0.043 | 0.007 | 0.006 |
Additional Paid-In Capital | 1035.46 | 1000.21 | 822.624 | 0.356 | 0 |
Retained Earnings (Accumulated Deficit) | -788.95 | -625.994 | -494.059 | -372.572 | -287.896 |
Unrealized Gain (Loss) | -0.564 | -0.184 | 0.001 | 0.022 | -0.06 |
Total Liabilities & Shareholders’ Equity | 400.115 | 463.464 | 403.829 | 88.366 | 151.13 |
Total Common Shares Outstanding | 48.465 | 47.241 | 42.722 | 45.2225 | 45.2225 |
Other Current Assets, Total | 0.7 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 337.275 | 373.645 | 310.003 | 345.777 | 377.426 |
Cash and Short Term Investments | 249.213 | 287.502 | 227.517 | 262.062 | 302.267 |
Cash & Equivalents | 36.386 | 73.222 | 63.877 | 75.497 | 114.346 |
Short Term Investments | 212.827 | 214.28 | 163.64 | 186.565 | 187.921 |
Total Receivables, Net | 34.314 | 28.07 | 22.512 | 24.627 | 26.899 |
Accounts Receivable - Trade, Net | 34.314 | 28.07 | 22.512 | 24.627 | 26.899 |
Total Inventory | 47.733 | 51.476 | 55.26 | 53.689 | 42.873 |
Prepaid Expenses | 6.015 | 6.597 | 4.714 | 5.399 | 5.387 |
Total Assets | 362.665 | 400.115 | 365.722 | 401.236 | 431.742 |
Property/Plant/Equipment, Total - Net | 21.012 | 21.993 | 22.022 | 21.932 | 20.844 |
Other Long Term Assets, Total | 4.378 | 4.477 | 33.697 | 33.527 | 33.472 |
Total Current Liabilities | 44.268 | 51.949 | 49.644 | 55.24 | 48.89 |
Accounts Payable | 1.988 | 0.603 | 1.444 | 2.753 | 5.149 |
Accrued Expenses | 27.957 | 35.575 | 34.041 | 36.973 | 30.789 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 14.323 | 15.771 | 14.159 | 14.514 | 12.952 |
Total Liabilities | 146.379 | 154.125 | 86.619 | 91.472 | 86.289 |
Total Long Term Debt | 96.48 | 96.336 | 29.828 | 28.806 | 29.784 |
Long Term Debt | 96.48 | 96.336 | 29.828 | 28.806 | 29.784 |
Other Liabilities, Total | 5.631 | 5.84 | 7.147 | 7.426 | 7.615 |
Total Equity | 216.286 | 245.99 | 279.103 | 309.764 | 345.453 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.049 | 0.048 | 0.048 | 0.048 | 0.048 |
Additional Paid-In Capital | 1049.27 | 1035.46 | 1027.49 | 1017.4 | 1008.94 |
Retained Earnings (Accumulated Deficit) | -832.921 | -788.95 | -747.506 | -706.725 | -662.886 |
Unrealized Gain (Loss) | -0.113 | -0.564 | -0.934 | -0.955 | -0.649 |
Total Liabilities & Shareholders’ Equity | 362.665 | 400.115 | 365.722 | 401.236 | 431.742 |
Total Common Shares Outstanding | 49.216 | 48.465 | 48.295 | 47.997 | 47.712 |
Current Port. of LT Debt/Capital Leases | 1 | ||||
Property/Plant/Equipment, Total - Gross | 32.8 | ||||
Accumulated Depreciation, Total | -10.807 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
Cash From Operating Activities | -145.729 | -130.264 | -99.015 | -70.292 | -46.442 |
Cash From Operating Activities | 5.169 | 5.162 | 3.159 | 1.484 | 1.069 |
Non-Cash Items | 33.2 | 22.112 | 25.167 | -1.878 | 2.486 |
Cash Taxes Paid | 0.385 | 0.083 | 0.019 | 0.035 | 0.009 |
Changes in Working Capital | -21.142 | -25.603 | -5.849 | -1.599 | -0.217 |
Cash From Investing Activities | -66.295 | -142.507 | 3.947 | 74.297 | -68.776 |
Capital Expenditures | -8.325 | -3.108 | -9.108 | -3.293 | -1.766 |
Other Investing Cash Flow Items, Total | -57.97 | -139.399 | 13.055 | 77.59 | -67.01 |
Cash From Financing Activities | 72.898 | 160.147 | 385.682 | 0.249 | 134.872 |
Financing Cash Flow Items | -0.181 | 0 | |||
Issuance (Retirement) of Stock, Net | 8.042 | 160.147 | 387.046 | 0.439 | 134.881 |
Issuance (Retirement) of Debt, Net | 64.856 | 0 | -1.364 | -0.009 | -0.009 |
Net Change in Cash | -139.126 | -112.624 | 290.614 | 4.254 | 19.654 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -43.971 | -162.956 | -121.512 | -80.731 | -36.892 |
Cash From Operating Activities | -44.756 | -145.729 | -111.222 | -76.91 | -38.335 |
Cash From Operating Activities | 1.384 | 5.169 | 3.9 | 2.586 | 1.262 |
Non-Cash Items | 8.598 | 33.2 | 23.826 | 15.118 | 6.581 |
Cash Taxes Paid | 0.201 | 0.385 | 0.334 | 0.283 | 0.205 |
Changes in Working Capital | -10.767 | -21.142 | -17.436 | -13.883 | -9.286 |
Cash From Investing Activities | 2.643 | -66.295 | -14.547 | -34.706 | -33.39 |
Capital Expenditures | -0.81 | -8.325 | -6.216 | -3.475 | -1.478 |
Other Investing Cash Flow Items, Total | 3.453 | -57.97 | -8.331 | -31.231 | -31.912 |
Cash From Financing Activities | 5.277 | 72.898 | 7.298 | 4.765 | 3.723 |
Issuance (Retirement) of Stock, Net | 5.277 | 8.042 | 7.433 | 4.765 | 3.723 |
Issuance (Retirement) of Debt, Net | 64.856 | ||||
Net Change in Cash | -36.836 | -139.126 | -118.471 | -106.851 | -68.002 |
Financing Cash Flow Items | -0.135 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Fidelity Management & Research Company LLC | Investment Advisor | 14.77 | 7270972 | 49376 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.4572 | 4655616 | 82430 | 2023-03-31 | LOW |
T. Rowe Price Investment Management, Inc. | Investment Advisor | 6.6916 | 3294148 | -225722 | 2023-03-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.2155 | 3059782 | -77314 | 2023-03-31 | LOW |
Bellevue Asset Management AG | Investment Advisor | 5.9047 | 2906759 | 63080 | 2023-03-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 5.5577 | 2735954 | 169738 | 2023-03-31 | LOW |
JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 3.8619 | 1901126 | 91339 | 2023-03-31 | LOW |
Champlain Investment Partners, LLC | Investment Advisor | 3.7109 | 1826825 | -33580 | 2023-03-31 | LOW |
Braidwell LP | Hedge Fund | 3.5637 | 1754350 | 49798 | 2023-03-31 | HIGH |
Mubadala Investment Company PJSC | Sovereign Wealth Fund | 2.9346 | 1444665 | -1445678 | 2021-12-07 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.6458 | 1302457 | 129782 | 2023-03-31 | LOW |
Eagle Health Investments LP | Hedge Fund | 2.4384 | 1200385 | -20224 | 2023-03-31 | MED |
Perceptive Advisors LLC | Private Equity | 2.213 | 1089427 | 0 | 2023-03-31 | MED |
C WorldWide Asset Management Fondsmaeglerselskab A/S | Investment Advisor | 2.0314 | 1000000 | 0 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8701 | 920601 | 35123 | 2023-03-31 | LOW |
Pura Vida Investments, LLC | Hedge Fund | 1.8671 | 919136 | 464746 | 2023-03-31 | HIGH |
RTW Investments L.P. | Investment Advisor/Hedge Fund | 1.6427 | 808658 | -100994 | 2023-03-31 | LOW |
Columbia Wanger Asset Management, LLC | Investment Advisor | 1.4124 | 695303 | 157420 | 2023-03-31 | MED |
Jennison Associates LLC | Investment Advisor/Hedge Fund | 1.2327 | 606819 | -3405 | 2023-03-31 | LOW |
Mellon Investments Corporation | Investment Advisor/Hedge Fund | 1.1932 | 587411 | -16224 | 2023-03-31 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Outset Medical, Inc. Company profile
About Outset Medical Inc
Outset Medical, Inc. is a medical technology company that offers Tablo. Tablo is a mobile integrated hemodialysis solution for acute and home hemodialysis therapy. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels and allows providers to access a single platform from the hospital to the home. The Tablo cartridge is a single use consumable intended to facilitate extracorporeal blood purification for patients and consists of a pre-configured blood, saline, and infusion tubing. Tablo’s touch screen panel enables the user to navigate through the treatment with animations and non-technical language, tailored to both professional and non-professional users. Tablo’s cloud connectivity software enables an ecosystem of machine diagnostics and analytics, treatment instruction, monitoring and reporting, improved documentation and remote machine management. In addition, Tablo also delivers robust clinical care.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Outset Medical Inc revenues increased from $49.9M to $102.6M. Net loss applicable to common stockholders increased 66% to $131.9M. Revenues reflect Consoles segment increase of 98% to $65.1M, Consumables segment increase from $6.7M to $19.2M. Higher net loss reflects Sales and marketing - Balancing value increase of 46% to $59.2M (expense).
Industry: | Advanced Medical Equipment & Technology (NEC) |
3052 Orchard Drive
SAN JOSE
CALIFORNIA 95134
US
Income Statement
- Annual
- Quarterly
News

USD/TRY forecast: Turkish lira under pressure from high inflation and low rates
We look at some of the latest USD/TRY predictions as the Turkish lira hits record lows.
17:07, 1 June 2023
Nvidia’s 5-year stock forecast: Will the chipmaker remain at record highs?
Nvidia has been the winner of the AI race, being the first chip-maker to hit a $1tn market cap. Will the growth continue?
07:46, 31 May 2023
Google stock forecast 2023-2025
What is the outlook for the tech giant, following a tumultuous 2022?
18:02, 30 May 2023
USD forecast: DXY slides in risk-off market sentiment
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
16:10, 24 May 2023
Oil price forecast: Will WTI and Brent regain momentum in 2023?
Discover the drivers behind Brent and WTI volatility and get insights from analyst predictions.
11:38, 22 May 2023
Weekly Roundup: Tech stocks lead the way
US stocks push higher as risk appetite surges despite the uncertainty
13:39, 19 May 2023
USD/JPY continues to build higher towards 138
USD/JPY advances towards the top of its ascending triangle as the US dollar moves higher
11:50, 17 May 2023People also watch
Still looking for a broker you can trust?
Join the 535.000+ traders worldwide that chose to trade with Capital.com